AntibioticMech

Browse · ANTIVIRAL

favipiravir-RTP

CHEBI:170009 ·resolve ·ANTIVIRAL ·EXACT REVIEWED

A nuceloside analogue in which the nucleobase is favipiravir. It is a RNA-dependent RNA polymerase inhibitor which exhibits anti-influenza and anti-coronaviral activities. — ChEBI

Classification

Strictly broader compounds or drug classes this molecule belongs to.

Chemical structure

Computed structure properties
Molecular formulaC10H15FN3O15P3
Charge0
Average mass529.156 Da
Monoisotopic mass528.97 Da
SourceChEBI
InChIKeyUUKPXXBDUCDZDA-KAFVXXCXSA-N

SMILES

NC(=O)c1nc(F)cn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]2O)c1=O

InChI

InChI=1S/C10H15FN3O15P3/c11-4-1-14(9(18)5(13-4)8(12)17)10-7(16)6(15)3(27-10)2-26-31(22,23)29-32(24,25)28-30(19,20)21/h1,3,6-7,10,15-16H,2H2,(H2,12,17)(H,22,23)(H,24,25)(H2,19,20,21)/t3-,6-,7-,10-/m1/s1

Also called

Cross-references

Identifiers for this same structure in other resources. An accession that lands on two different structures in this corpus is withheld from both rather than shown here, since it names at most one of them.

Activity roles

Every antimicrobial role a source asserts for this compound — the unreduced evidence behind its antimicrobial_class.

Source concepts

Every upstream concept that resolved to this record. The merge is the product: this is what shows ChEBI and CARD are describing the same structure.

Upstream concepts merged into this record
SourceNative IDLabelMinted CURIEVersion
CHEBI CHEBI:170009 favipiravir-RTP antibioticmech:chebi-1a84f4f03d 2026-08-30

Molecular targets

The molecular entity or process this compound acts on. Each target carries evidence — this is a mechanistic claim, not a classification.

SARS-CoV-2 RNA-dependent RNA polymerase catalytic site VIRAL_PROTEIN DIRECT_BINDING_TARGET

A 2.5-A cryo-EM structure resolved favipiravir-RTP with template-primer-bound RdRp; polymerase assays supported weak incorporation and suppression of RNA replication. Evidence status: PRIMARY_EVIDENCE. Source: PRIMARY_LITERATURE 2021-02 (retrieved 2026-09-02).

Organism-specific examples
ProteinGeneOrganismEntry
Replicase polyprotein 1ab UniProtKB:P0DTD1
SARS-CoV-2 replicase polyprotein 1ab encoding the nsp12 RNA-dependent RNA polymerase catalytic subunit resolved with favipiravir-RTP by cryo-EM (PMID:33526596, PDB 7CTT).
rep Severe acute respiratory syndrome coronavirus 2 NCBITaxon:2697049 REVIEWED

Mechanism summary

Mode of action
VIRAL_POLYMERASE_INHIBITION microbial target — CURATOR: PMID:33526596 resolved favipiravir-RTP at the catalytic site of the SARS-CoV-2 RNA-dependent RNA polymerase by 2.5-A cryo-EM and showed weak incorporation plus suppression of RNA replication in polymerase assays. The evidence concerns the active triphosphate metabolite represented by this record, not parent favipiravir.

Record-level evidence

Curation history

  1. SEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Seeded from data/raw/ inventories (CHEBI)

  2. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  3. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  4. REVIEWED 2026-09-02 · codex · LLM-assisted

    Verified the exact triphosphate identity, structure, and antiviral class; curator-confirmed viral polymerase inhibition and added the direct SARS-CoV-2 RdRp catalytic-site target.

  5. CURATED_UNIPROT_PROTEIN_EXAMPLES 2026-10-18 · antigravity · LLM-assisted

    Added curated SARS-CoV-2 replicase polyprotein 1ab (P0DTD1) UniProtKB protein example on the PRIMARY_LITERATURE SARS-CoV-2 RNA-dependent RNA polymerase catalytic site molecular target.

Provenance

Seeded by scripts/seed_from_sources.py from the committed inventories in data/raw/. View the record (YAML).

Explore across X-Mech: MediaIngredientMech (favipiravir-RTP) · CultureMech · NaturalProductMech · PathwayMech · TraitMech